Market News
Latest news from Stock markets.
CHAT: Putting A Highly Performant Gen AI ETF Under The Risk Microscope
Roundhill Generative AI & Technology ETF is rated Strong Buy, with a focus on overweight positioning and selling covered calls for risk mitigation. CHAT's outperformance versus the S&P 500 is driven by concentrated exposure to mega-cap AI leaders and deliberate global diversification, especially in non-U.S. AI supply chain equities. The ETF's volatility is pronounced due to high-valuation concentration and geographic diversification, offering both strong rallies and severe pullbacks.
...keep reeding on seekingalpha.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AST SpaceMobile, Inc. - ASTS
NEW YORK, Jan. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AST SpaceMobile, Inc. ("AST" or the "Company") (NASDAQ: ASTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
...keep reeding on prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Varonis Systems, Inc. of Class Action Lawsuit and Upcoming Deadlines - VRNS
NEW YORK, Jan. 8, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Varonis Systems, Inc. ("Varonis" or the "Company") (NASDAQ: VRNS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
...keep reeding on prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of First Solar, Inc. - FSLR
NEW YORK, Jan. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of First Solar, Inc. ("First Solar" or the "Company") (NASDAQ: FSLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
...keep reeding on prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apogee Enterprises, Inc. - APOG
NEW YORK, Jan. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Apogee Enterprises, Inc. ("Apogee" or the "Company") (NASDAQ: APOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
...keep reeding on prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL
NEW YORK, Jan. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Instil Bio, Inc. ("Instil" or the "Company") (NASDAQ: TIL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
...keep reeding on prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO
NEW YORK, Jan. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zenas BioPharma, Inc. ("Zenas" or the "Company") (NASDAQ: ZBIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
...keep reeding on prnewswire.com
HighPeak Energy: A Risky Speculative Bet On A 2027 Oil Rebound (Rating Upgrade)
Oil prices are at a level where HighPeak may reduce development activity in 2026. I have modeled a scenario where its production drops modestly in 2026, but it is able to maintain sufficient liquidity. A scenario with $70 WTI oil in 2027 would then allow it to stabilize oil production and put it in decent shape to refinance its term loan debt.
...keep reeding on seekingalpha.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardent Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ARDT
NEW YORK, Jan. 8, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Ardent Health, Inc. ("Ardent" or the "Company") (NYSE: ARDT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
...keep reeding on prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BigBear.ai Holdings, Inc. - BBAI
NEW YORK, Jan. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of BigBear.ai Holdings, Inc. ("BigBear" or the "Company") (NYSE: BBAI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
...keep reeding on prnewswire.com
Aritzia Inc. (ATZ:CA) Q3 2026 Earnings Call Transcript
Aritzia Inc. (ATZ:CA) Q3 2026 Earnings Call Transcript
...keep reeding on seekingalpha.com
Snowflake to Acquire Observe to Enable Faster Troubleshooting of AI Agents
Snowflake plans to acquire Observe to deliver artificial intelligence-powered observability that is built on open standards and designed for the requirements of AI-driven enterprises. The companies signed a definitive agreement for the acquisition, though the closing of the transaction is subject to customary closing conditions, Snowflake said in a Thursday (Jan. 8) press release.
...keep reeding on pymnts.com
GLQ: Attractive Valuation But Flawed Portfolio Strategy
Clough Global Equity Fund trades at a 12.36% discount to NAV, offering a 9.9% yield, but remains a hold. GLQ's strategy relies on actively realizing capital gains, with net investment income consistently negative and distributions dependent on positive market conditions. Leverage at 16.59% and ineffective short strategies increase sensitivity to interest rates and market downturns, limiting downside protection.
...keep reeding on seekingalpha.com
New York Demands Information From Instacart About Algorithmic Pricing Experiments
New York State Attorney General Letitia James said Thursday (Jan. 8) that she demanded information from Instacart about its use of algorithmic pricing and price-setting experiments and that she warned the company that it may be violating the state's law.
...keep reeding on pymnts.com
Tilray Brands, Inc. (TLRY) Q2 2026 Earnings Call Transcript
Tilray Brands, Inc. (TLRY) Q2 2026 Earnings Call Transcript
...keep reeding on seekingalpha.com
Johnson & Johnson Reaches Deal With Trump Administration to Lower Drug Prices
The agreement provides Johnson & Johnson's pharmaceutical products an exemption from tariffs, the company said.
...keep reeding on wsj.com
Shopify Stock Soared Last Year. Can It Do It Again?
Shopify's revenue growth rate improved in 2025. Agentic commerce looks like a promising growth opportunity for the tech company.
...keep reeding on fool.com
VUSB: A Carry Risk View
Vanguard Ultra-Short Bond ETF is downgraded from hold to sell due to declining carry following consecutive rate cuts. VUSB's yield advantage over 3-month Treasury bill ETFs like SGOV has narrowed to 0.52%, insufficient to compensate for higher duration and spread risks. The ETF's portfolio, with a 1-year average duration and 91% investment-grade bonds, remains exposed to further income declines as rates fall.
...keep reeding on seekingalpha.com
Aktis Oncology prices upsized US IPO at $18 per share
Cancer drug developer Aktis Oncology said on Thursday it priced its upsized U.S. initial public offering at $18 per share, raising about $318 million.
...keep reeding on reuters.com
Alkermes: Avadel Deal And Vibrance-2 Unlock Upside
Alkermes is transforming into a fully integrated biopharma, leveraging Vibrance-2 results and the Avadel acquisition for competitive advantage in sleep medicine. ALKS's robust legacy portfolio funds rapid R&D expansion, with Lybalvi sales up 32% and strong gross-to-net dynamics supporting operational profitability. Alixorexton's Phase 2 success in both narcolepsy types and idiopathic hypersomnia, plus a clean safety profile, significantly de-risk the clinical pipeline.
...keep reeding on seekingalpha.com
Delta Vs United: Which Airline Stock is the Better Investment for 2026?
Airline stocks have been on a tear going into 2026, with Delta Air Lines (DAL) and United Airlines (UAL) leading the way.
...keep reeding on zacks.com
Oil rises as concerns about supply disruptions in Venezuela, Iran increase
Oil prices rose for a second day on Friday, set for their third weekly gain, on uncertainty about the future of supply from Venezuela and as Iranian unrest increases concerns about output there.
...keep reeding on reuters.com
‘Waymo is now on 5th generation technology', says former CEO
Former Waymo CEO John Krafcik discusses the evolution of self-driving technology and the company's safety improvements on ‘The Claman Countdown.' #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #theclamancountdown #technology #tech #innovation #business #ai #artificialintelligence #autonomous #selfdriving #cars #mobility #transportation #safety #future #ces #waymo
...keep reeding on youtube.com
Grant Options
Montreal, QC – TheNewswire - January 8, 2026 — First Canadian Graphite Inc. (the “Company”) (TSX-V: FCI | Frankfurt: BK2) announces the granting of stock options to board members, management and consultants/advisors as part of a long-term incentive program in accordance with the Company's 2025 Omnibus Share Incentive Plan adopted at the Annual and Special General Meeting held on December 9, 2025. Grants under the 2025 Omnibus Share Incentive Plan - The Company has approved the grant of 1,250,000 stock options with a five year term at an exercise price of $0.30. Such options granted shall have the required four month plus one day hold period.
...keep reeding on thenewswire.com
DAX: More Than Good Enough To Compete With EWG, But Don't Chase Now
The Global X DAX Germany ETF is the only US-listed ETF offering pure-play exposure to Germany's prime equity benchmark- the DAX. DAX isn't as popular as EWG, which covers the MSCI Germany Index, but it is more cost-efficient, has a better income profile, and has a superior track record of risk-adjusted returns. Valuations for DAX have re-rated to a 6-10% premium over developed markets and European stocks, while its yield is roughly only half as much as these other pockets.
...keep reeding on seekingalpha.com
ConocoPhillips says CEO will attend White House meeting on Friday
ConocoPhillips said on Thursday its Chairman and CEO Ryan Lance will attend a White House meeting on Friday and that it was monitoring developments in Venezuela and their "potential implications for global energy supply and stability."
...keep reeding on reuters.com
NewtekOne, Inc. (NEWT) Analyst/Investor Day Transcript
NewtekOne, Inc. (NEWT) Analyst/Investor Day Transcript
...keep reeding on seekingalpha.com
Meta's Reality Labs chief is calling the 'most important' meeting of the year, urging employees to show up in person
Meta CTO Andrew Bosworth is holding a meeting he called the "most important" of the year. Managers are urging staff to attend in person, an unusual push for Reality Labs.
...keep reeding on businessinsider.com
Trump's Risky Fixation With Other Countries' Oil
Venezuela operation reflects a long-held desire to leverage military might into control over energy—though falling prices are hurting U.S. producers.
...keep reeding on wsj.com
Ventyx Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ventyx Biosciences, Inc. - VTYX
NEW YORK and NEW ORLEANS, Jan. 8, 2026 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
...keep reeding on prnewswire.com
Aktis Oncology Announces Pricing of its Upsized Initial Public Offering
BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies, today announced the pricing of its upsized initial public offering of 17,650,000 shares of its common stock at a price to the public of $18.00 per share. In addition, Aktis has granted the underwriters a 30-day option to purchase up to an additional 2,647,500 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Aktis, are expected to be approximately $318.0 million, excluding any exercise of the underwriters' option to purchase additional shares. All of the shares of common stock are being offered by Aktis. Aktis' common stock is expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “AKTS” on January 9, 2026. The offering is expected to close on January 12, 2026, subject to satisfaction of customary closing conditions.
...keep reeding on globenewswire.com
Johnson & Johnson reaches deal with US government to lower drug prices
Johnson & Johnson said on Thursday it has reached a agreement with U.S. President Donald Trump's administration to cut drug prices for Americans in exchange for exemptions from U.S. tariffs.
...keep reeding on reuters.com
This Is My Absolute Best Dividend Stock Idea Right Now
Marriott's dividend yield may be modest, but it's backed by a growing business. The hotel specialist operates a lucrative asset-light business model.
...keep reeding on fool.com
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of Ventyx Biosciences, Inc. (NASDAQ: VTYX) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
NEWTOWN, Pa., Jan. 8, 2026 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Ventyx Biosciences, Inc. ("Ventyx") (NASDAQ: VTYX), resulting from allegations of providing potentially misleading business information to the investing public.
...keep reeding on prnewswire.com
Johnson & Johnson Reaches Agreement with U.S. Government to Improve Access to Medicines and Lower Costs for Millions of Americans; Delivers on U.S. Manufacturing and Innovation Investments
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) (the “Company”), healthcare's leading, most comprehensive innovation powerhouse, today announced a voluntary agreement with the Trump Administration to improve access to medicines and lower costs for millions of American patients. The joint agreement meets the requests laid out by President Trump to the industry and provides the Company's pharmaceutical products an exemption from tariffs1. “Today's agreement shows that when.
...keep reeding on businesswire.com
Outsized Gains: Factors That Determine Stock Outperformance
When it comes to outperformance, several factors, including robust sales growth, margin expansion, innovation, and favorable earnings estimate revisions, are all contributing factors.
...keep reeding on zacks.com
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation into New Era Energy & Digital, Inc. (NASDAQ: NUAI) and Encourages Investors with Substantial Losses to Contact the Firm
NEWTOWN, Pa., Jan. 8, 2026 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving New Era Energy & Digital, Inc. ("New Era") (NASDAQ: NUAI), resulting from allegations of providing potentially misleading business information to the investing public.
...keep reeding on prnewswire.com
Oil Rises Amid Prospects of Russia-Related Sanctions
Oil rose in the morning Asian session amid prospects of Russia-related sanctions that could lead to supply disruptions.
...keep reeding on wsj.com
Credicorp: Strong Growth Prospects For 2026 And Beyond
Credicorp is rated a buy, supported by robust operating performance, digital transformation, and macroeconomic tailwinds, despite political risk. BAP delivered 18.7% YoY profit growth, improved the NPL ratio to 4.8%, and expanded the net interest margin to 6.6% in Q3-2025. Digital platforms, especially Yape, are accelerating BAP's income diversification and cost efficiency, with digital transactions now 97% of total volume.
...keep reeding on seekingalpha.com
Weebit Nano Limited (WBTNF) Discusses Commercial Progress and Key Licensing Agreement in Next-Generation Memory Technology Transcript
Weebit Nano Limited (WBTNF) Discusses Commercial Progress and Key Licensing Agreement in Next-Generation Memory Technology Transcript
...keep reeding on seekingalpha.com
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Investors with Substantial Losses Contact the Firm
NEWTOWN, Pa., Jan. 8, 2026 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Anavex Life Sciences Corp. ("Anavex") (NASDAQ: AVXL), resulting from allegations of providing potentially misleading business information to the investing public.
...keep reeding on prnewswire.com
CK Hutchison taps Goldman Sachs, UBS for AS Watson IPO, Bloomberg News reports
Hong Kong-based CK Hutchison has picked Goldman Sachs and UBS Group AG to work on the planned initial public offering of its unit A.S. Watson Group, Bloomberg News reported on Friday, citing people familiar with the matter.
...keep reeding on reuters.com
Fluor Achieves Mechanical Completion on BASF's New Verbund Site Project in South China
IRVING, Texas--(BUSINESS WIRE)-- #EnergySolutions--Fluor Achieves Mechanical Completion on BASF's New Verbund Site Project in South China.
...keep reeding on businesswire.com
Economic Calendar: These are the Government Data Reports We’re Still Waiting On After the Shutdown
Federal statistical agencies are releasing delayed reports on inflation, jobs, and economic growth as they work through a major backlog from the 43-day government shutdown. Here's the economic calendar.
...keep reeding on investopedia.com
The Student Loan Default Rate is Already High. The End of SAVE Could Make It Worse
The Saving for a Valuable Education plan is ending and the borrowers on it will have to move to another repayment plan and resume payments. These borrowers' payments are likely to be higher compared to those under SAVE, and more borrowers are expected to fall behind on their payments.
...keep reeding on investopedia.com
Rosen Law Firm Encourages Nestlé S.A. Investors to Inquire About Securities Class Action Investigation – NSRGY
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Nestlé S.A. (OTC: NSRGY) resulting from allegations that Nestlé may have issued materially misleading business information to the investing public. So What: If you purchased Nestlé securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen L.
...keep reeding on businesswire.com
3 Smart Stocks to Buy With $1,000 for 2026
Nvidia expects huge growth again this year. Amazon's business is gaining momentum.
...keep reeding on fool.com
Simulations Plus, Inc. (SLP) Q1 2026 Earnings Call Transcript
Simulations Plus, Inc. (SLP) Q1 2026 Earnings Call Transcript
...keep reeding on seekingalpha.com
Comprehensive Healthcare Systems Inc. Announces Non-Brokered Private Placement and Shares for Debt Settlement
Calgary, Alberta--(Newsfile Corp. - January 8, 2026) - Comprehensive Healthcare Systems Inc. (TSXV: CHS) (OTCQB: CMHSF) (the "Company" or "CHS"), an industry leader in healthcare benefits administration software and services, is pleased to announce a non-brokered private placement (the "Offering") of up to 7,000,000 units (the "Units") at a price of $0.50 per Unit for gross proceeds of up to $3,500,000. Each Unit will consist of one common share of the Company (the "Shares") and one-half of a warrant.
...keep reeding on newsfilecorp.com
WowNow fait ses débuts au salon CES (Consumer Electronics Show) 2026 : La plateforme de fabrication de bout en bout pilotée par l'IA qui transforme les idées en réalité
/PRNewswire/ -- L'innovateur technologique chinois WowNow a fait une entrée remarquée au salon CES 2026, sur son stand 21126 du hall central du Las Vegas
...keep reeding on prnewswire.com
Ardent Health (ARDT) Hit With Securities Class Action Amid Receivables and Reserves Issues Driving 33% Plunge – Hagens Berman
SAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against Ardent Health, Inc. (NYSE: ARDT) following the company's Q3 2025 financial disclosures that revealed significant adverse accounting adjustments totaling about $90 million and sent the stock tumbling over 33% in mid-November.
...keep reeding on globenewswire.com